MPDNHNFHEKDRRB-UHFFFAOYSA-N
C32H35Cl2F6N7O4S — CID 159631187
Data last refreshed: (MolForge compound catalog, from PubChem)
About MPDNHNFHEKDRRB-UHFFFAOYSA-N
MPDNHNFHEKDRRB-UHFFFAOYSA-N (PubChem CID 159631187) has the molecular formula C32H35Cl2F6N7O4S and a molecular weight of 798.64 g/mol. Its IUPAC name is 1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine;[4-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazin-1-yl]-(5-methylsulfonyl-2-morpholin-4-ylphenyl)methanone.
Molecular Properties
| Compound Name | MPDNHNFHEKDRRB-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 159631187 |
| Molecular Formula | C32H35Cl2F6N7O4S |
| Molecular Weight | 798.64 g/mol |
| Exact Mass | 797.18 |
| IUPAC Name | 1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine;[4-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazin-1-yl]-(5-methylsulfonyl-2-morpholin-4-ylphenyl)methanone |
| SMILES | CS(=O)(=O)c1ccc(N2CCOCC2)c(C(=O)N2CCN(c3ncc(C(F)(F)F)cc3Cl)CC2)c1.FC(F)(F)c1cnc(N2CCNCC2)c(Cl)c1 |
| InChI | InChI=1S/C22H24ClF3N4O4S.C10H11ClF3N3/c1-35(32,33)16-2-3-19(28-8-10-34-11-9-28)17(13-16)21(31)30-6-4-29(5-7-30)20-18(23)12-15(14-27-20)22(24,25)26;11-8-5-7(10(12,13)14)6-16-9(8)17-3-1-15-2-4-17/h2-3,12-14H,4-11H2,1H3;5-6,15H,1-4H2 |
| InChIKey | MPDNHNFHEKDRRB-UHFFFAOYSA-N |
| XLogP | 5.12 |
| TPSA | 111.21 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 52 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 798.64 |
| LogP ≤ 5 | 5.12 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159631187 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.